Product Code: GVR-1-68038-353-9
Mammography Market Growth & Trends
The global mammography market size is expected to reach USD 4.7 billion by 2030, registering a CAGR of 10.3% according to a new report by Grand View Research, Inc. The growth is mainly driven by the rising initiatives by various governments and NGOs to raise awareness about the early diagnosis of microcalcifications in breast tissue.
For instance, the National Breast Cancer Screening Programme in the Netherlands, for example, was created for women aged 50 to 75. According to the program, women in this age bracket were invited for a mammogram every two years. Similarly, in Australia, women aged 50 to 74 are required to have free mammograms every 2 years as part of the government's national screening program, Breast Screen Australia. Some other significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting early diagnosis of mammary gland calcification. This is one of the crucial factors expected to drive market growth.
Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years. For instance, in March 2018, Siemens Healthineers obtained U.S. FDA approval for its enhanced mammography platform MAMMOMAT Revelation. This platform is combined with a new InSpect specimen imaging tool as well as new HD Breast Biopsy technology for one-click targeting of affected areas. Moreover, in October 2021, iCAD, Inc. launched its latest generation of ProFound AI for 2D Mammography.
Furthermore, the use of Artificial Intelligence (AI) in 3D mammography has reduced exam time while maintaining image quality. For instance, in March 2021, iCad received USFDA approval for its ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) system. Compared to previous versions of the software, it provides up to a 10% enhancement in specificity performance, up to 1% improvement in sensitivity, and offers 40% faster processing. Thus, rapid FDA approval for AI-enabled 3D mammography equipment is driving market growth.
Mammography Market Report Highlights
- Digital systems dominated the product segment in 2022 owing to the wide availability of digital breast screening devices and the presence of favorable reimbursements for such devices
- Digital mammography dominated the technology segment in 2022 due to growing awareness regarding digital technology and increasing adoption of such technology for better diagnosis
- In 2022, North America dominated due to the increasing adoption of technologically advanced screening devices and the upsurging number of approvals of 3D systems
- Asia Pacific and Latin America are the two fastest-growing regional segments, because of the higher mammary gland cancer prevalence and the growing number of government campaigns to improve breast
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Research Methodology
- 1.1.1 Information procurement
- 1.2 Information or Data Analysis
- 1.3 Market Formulation & Validation
- 1.4 Region Wise Market Calculation
- 1.4.1 Region Wise Market: Base Estimates
- 1.4.2 Global Market: CAGR Calculation
- 1.5 Region Based Segment Share Calculation
- 1.6 List of Secondary Sources
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Business Segment Trends
- 2.4 Market Snapshot
- 2.5 Penetration & Growth Prospect Mapping
- 2.6 Market Dynamics
- 2.6.1 Market driver analysis
- 2.6.1.1 Rising prevalence of breast cancer
- 2.6.1.2 Favorable government initiatives
- 2.6.1.3 Introduction of innovative technology-based products
- 2.6.2 Market restraint analysis
- 2.6.2.1 High cost of mammography systems
- 2.6.2.2 Stringent regulatory policies
- 2.7 Mammography Market Analysis Tools
- 2.7.1 SWOT Analysis, by PEST
- 2.7.2 Porter's five forces analysis
Chapter 3 Mammography Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
- 3.1 Definitions & Scope
- 3.2 Product Market Share Analysis, 2022 & 2030
- 3.3 Global Mammography Market, by Product, 2018 to 2030
- 3.4 Market Size Forecasts and Trend Analysis
- 3.4.1 Film Screen Systems
- 3.4.1.1 Film screen systems market, 2018 - 2030 (USD Million)
- 3.4.2 Digital Systems
- 3.4.2.1 Digital systems market, 2018 - 2030 (USD Million)
- 3.4.3 Analog Systems
- 3.4.3.1 Analog systems market, 2018 - 2030 (USD Million)
- 3.4.4 3D Systems
- 3.4.4.1 3D systems market, 2018 - 2030 (USD Million)
Chapter 4 Mammography Market: Segment Analysis, by Technology, 2018 - 2030 (USD Million)
- 4.1 Definitions & Scope
- 4.2 Technology Market Share Analysis, 2022 & 2030
- 4.3 Global Mammography Market, by Technology, 2018 to 2030
- 4.4 Market Size Forecasts & Trend Analysis
- 4.4.1 Breast Tomosynthesis Technology
- 4.4.1.1 Breast tomosynthesis technology market, 2018 - 2030 (USD Million)
- 4.4.2 CAD Mammography Technology
- 4.4.2.1 CAD mammography technology market, 2018 - 2030 (USD Million)
- 4.4.3 Digital Mammography Technology
- 4.4.3.1 Digital mammography technology market, 2018 - 2030 (USD Million)
Chapter 5 Mammography Market: Segment Analysis, by End-use, 2018 - 2030 (USD Million)
- 5.1 Definitions & Scope
- 5.2 End-use Market Share Analysis, 2022 & 2030
- 5.3 Global Mammography Market, by End-use, 2018 to 2030
- 5.4 Market Size Forecasts & Trend Analysis
- 5.4.1 Hospitals
- 5.4.1.1 Hospitals market, 2018 - 2030 (USD Million)
- 5.4.2 Specialty Clinics
- 5.4.2.1 Specialty clinics market, 2018 - 2030 (USD Million)
- 5.4.3 Diagnosis Centers
- 5.4.3.1 Diagnosis centers market, 2018 - 2030 (USD Million)
- 5.4.3 Others
- 5.4.3.1 Others market, 2018 - 2030 (USD Million)
Chapter 6 Mammography Market: Regional Market Analysis, By Product, Technology, End-use, 2018 - 2030 (USD Million)
- 6.1 Definitions & Scope
- 6.2 Regional Market Share Analysis, 2022 & 2030
- 6.3 Regional Market Snapshot
- 6.4 Market Size Forecasts & Trend Analysis
- 6.4.1 North America
- 6.4.1.1 North America mammography market, 2018 - 2030 (USD Million)
- 6.4.1.2 U.S.
- 6.4.1.2.1 Key Country Dynamics
- 6.4.1.2.2 Regulatory Framework & Reimbursement Structure
- 6.4.1.2.3 Competitive Scenario
- 6.4.1.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.3 Canada
- 6.4.1.3.1 Key Country Dynamics
- 6.4.1.3.2 Regulatory Framework & Reimbursement Structure
- 6.4.1.3.3 Competitive Scenario
- 6.4.1.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.2 Europe
- 6.4.2.1 Europe mammography market, 2018 - 2030 (USD Million)
- 6.4.2.2 UK
- 6.4.2.2.1 Key Country Dynamics
- 6.4.2.2.2 Regulatory Framework & Reimbursement Structure
- 6.4.2.2.3 Competitive Scenario
- 6.4.2.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.3 Germany
- 6.4.2.3.1 Key Country Dynamics
- 6.4.2.3.2 Regulatory Framework & Reimbursement Structure
- 6.4.2.3.3 Competitive Scenario
- 6.4.2.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.4 France
- 6.4.2.4.1 Key Country Dynamics
- 6.4.2.4.2 Regulatory Framework & Reimbursement Structure
- 6.4.2.4.3 Competitive Scenario
- 6.4.2.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.5 Italy
- 6.4.2.5.1 Key Country Dynamics
- 6.4.2.5.2 Regulatory Framework & Reimbursement Structure
- 6.4.2.5.3 Competitive Scenario
- 6.4.2.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.6 Spain
- 6.4.2.6.1 Key Country Dynamics
- 6.4.2.6.2 Regulatory Framework & Reimbursement Structure
- 6.4.2.6.3 Competitive Scenario
- 6.4.2.6.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.7 Denmark
- 6.4.2.7.1 Key Country Dynamics
- 6.4.2.7.2 Regulatory Framework & Reimbursement Structure
- 6.4.2.7.3 Competitive Scenario
- 6.4.2.7.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.8 Sweden
- 6.4.2.8.1 Key Country Dynamics
- 6.4.2.8.2 Regulatory Framework & Reimbursement Structure
- 6.4.2.8.3 Competitive Scenario
- 6.4.2.8.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.9 Norway
- 6.4.2.9.1 Key Country Dynamics
- 6.4.2.9.2 Regulatory Framework & Reimbursement Structure
- 6.4.2.9.3 Competitive Scenario
- 6.4.2.9.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.3 Asia Pacific
- 6.4.3.1 Asia Pacific mammography market, 2018 - 2030 (USD Million)
- 6.4.3.2 Japan
- 6.4.3.2.1 Key Country Dynamics
- 6.4.3.2.2 Regulatory Framework & Reimbursement Structure
- 6.4.3.2.3 Competitive Scenario
- 6.4.3.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.3.3 China
- 6.4.3.3.1 Key Country Dynamics
- 6.4.3.3.2 Regulatory Framework & Reimbursement Structure
- 6.4.3.3.3 Competitive Scenario
- 6.4.3.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.3.4 India
- 6.4.3.4.1 Key Country Dynamics
- 6.4.3.4.2 Regulatory Framework & Reimbursement Structure
- 6.4.3.4.3 Competitive Scenario
- 6.4.3.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.3.5 Australia
- 6.4.3.5.1 Key Country Dynamics
- 6.4.3.5.2 Regulatory Framework & Reimbursement Structure
- 6.4.3.5.3 Competitive Scenario
- 6.4.3.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.3.6 South Korea
- 6.4.3.6.1 Key Country Dynamics
- 6.4.3.6.2 Regulatory Framework & Reimbursement Structure
- 6.4.3.6.3 Competitive Scenario
- 6.4.3.6.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.3.7 Thailand
- 6.4.3.7.1 Key Country Dynamics
- 6.4.3.7.2 Regulatory Framework & Reimbursement Structure
- 6.4.3.7.3 Competitive Scenario
- 6.4.3.7.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.4 Latin America
- 6.4.4.1 Latin America mammography market, 2018 - 2030 (USD Million)
- 6.4.4.2 Brazil
- 6.4.4.2.1 Key Country Dynamics
- 6.4.4.2.2 Regulatory Framework & Reimbursement Structure
- 6.4.4.2.3 Competitive Scenario
- 6.4.4.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.4.3 Mexico
- 6.4.4.3.1 Key Country Dynamics
- 6.4.4.3.2 Regulatory Framework & Reimbursement Structure
- 6.4.4.3.3 Competitive Scenario
- 6.4.4.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.4.4 Argentina
- 6.4.4.4.1 Key Country Dynamics
- 6.4.4.4.2 Regulatory Framework & Reimbursement Structure
- 6.4.4.4.3 Competitive Scenario
- 6.4.4.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.4.5 Colombia
- 6.4.4.5.1 Key Country Dynamics
- 6.4.4.5.2 Regulatory Framework & Reimbursement Structure
- 6.4.4.5.3 Competitive Scenario
- 6.4.4.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.5 MIddle East & Africa (MEA)
- 6.4.5.1 MEA mammography market, 2018 - 2030 (USD Million)
- 6.4.5.2 South Africa
- 6.4.5.2.1 Key Country Dynamics
- 6.4.5.2.2 Regulatory Framework & Reimbursement Structure
- 6.4.5.2.3 Competitive Scenario
- 6.4.5.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.5.3 Saudi Arabia
- 6.4.5.3.1 Key Country Dynamics
- 6.4.5.3.2 Regulatory Framework & Reimbursement Structure
- 6.4.5.3.3 Competitive Scenario
- 6.4.5.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.5.4 UAE
- 6.4.5.4.1 Key Country Dynamics
- 6.4.5.4.2 Regulatory Framework & Reimbursement Structure
- 6.4.5.4.3 Competitive Scenario
- 6.4.5.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 6.4.5.5 Kuwait
- 6.4.5.5.1 Key Country Dynamics
- 6.4.5.5.2 Regulatory Framework & Reimbursement Structure
- 6.4.5.5.3 Competitive Scenario
- 6.4.5.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 7 Mammography Market: Competitive Landscape
- 7.1 Company Profiles
- 7.1.1 Hologic Inc.
- 7.1.1.1 Company overview
- 7.1.1.2 Financial performance
- 7.1.1.3 Product benchmarking
- 7.1.1.4 Strategic initiatives
- 7.1.2 Analogic Corporation
- 7.1.2.1 Company overview
- 7.1.2.1 Financial performance
- 7.1.2.2 Product benchmarking
- 7.1.2.3 Strategic initiatives
- 7.1.3 Canon Medical Systems Corporation
- 7.1.3.1 Company overview
- 7.1.3.2 Financial performance
- 7.1.3.3 Product benchmarking
- 7.1.3.4 Strategic initiatives
- 7.1.4 Fujifilm Corporation
- 7.1.4.1 Company overview
- 7.1.4.2 Financial Performance
- 7.1.4.3 Product benchmarking
- 7.1.4.4 Strategic initiatives
- 7.1.5 Siemens Healthcare
- 7.1.5.1 Company overview
- 7.1.5.2 Financial performance
- 7.1.5.3 Product benchmarking
- 7.1.5.4 Strategic initiatives
- 7.1.6 Toshiba Medical Systems
- 7.1.6.1 Company overview
- 7.1.6.2 Financial performance
- 7.1.6.3 Product benchmarking
- 7.1.6.4 Strategic initiatives
- 7.1.7 GE Healthcare
- 7.1.7.1 Company overview
- 7.1.7.2 Financial performance
- 7.1.7.3 Product benchmarking
- 7.1.7.4 Strategic initiatives
- 7.1.8 Metaltronica
- 7.1.8.1 Company overview
- 7.1.8.2 Financial performance
- 7.1.8.3 Product benchmarking
- 7.1.8.4 Strategic initiatives
- 7.1.9 Koninklijke Philips NV
- 7.1.9.1 Company overview
- 7.1.9.2 Financial performance
- 7.1.9.3 Product benchmarking
- 7.1.9.4 Strategic initiatives
- 7.1.10 PLANMED OY
- 7.1.10.1 Company overview
- 7.1.10.2 Financial performance
- 7.1.10.3 Product benchmarking
- 7.1.10.4 Strategic initiatives